Pavmed Inc Stock Profit Margin
| PAVM Stock | USD 0.50 0.03 6.28% |
Fundamental analysis of PAVmed allows traders to better anticipate movements in PAVmed's stock price by examining its financial health and performance throughout various phases of its business cycle.
| Last Reported | Projected for Next Year | ||
| Net Profit Margin | 13.29 | 13.95 |
PAVmed | Profit Margin | Build AI portfolio with PAVmed Stock |
PAVmed Inc Company Profit Margin Analysis
PAVmed's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current PAVmed Profit Margin | 37.12 % |
Most of PAVmed's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, PAVmed Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
PAVmed Profit Margin Driver Correlations
Understanding the fundamental principles of building solid financial models for PAVmed is extremely important. It helps to project a fair market value of PAVmed Stock properly, considering its historical fundamentals such as Profit Margin. Since PAVmed's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of PAVmed's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of PAVmed's interrelated accounts and indicators.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
PAVmed Pretax Profit Margin
Pretax Profit Margin |
|
Based on the latest financial disclosure, PAVmed Inc has a Profit Margin of 37.1154%. This is 431.09% lower than that of the Health Care Equipment & Supplies sector and notably lower than that of the Health Care industry. The profit margin for all United States stocks is notably lower than that of the firm.
Did you try this?
Run Fundamentals Comparison Now
Fundamentals ComparisonCompare fundamentals across multiple equities to find investing opportunities |
| All Next | Launch Module |
PAVmed Fundamentals
| Return On Equity | 0.64 | ||||
| Return On Asset | -0.5 | ||||
| Profit Margin | 37.12 % | ||||
| Operating Margin | (680.75) % | ||||
| Current Valuation | 43.91 M | ||||
| Shares Outstanding | 17.29 M | ||||
| Shares Owned By Insiders | 22.22 % | ||||
| Shares Owned By Institutions | 7.06 % | ||||
| Number Of Shares Shorted | 229.83 K | ||||
| Price To Earning | (6.39) X | ||||
| Price To Book | 0.48 X | ||||
| Price To Sales | 4.57 X | ||||
| Revenue | 3 M | ||||
| Gross Profit | (1.14 M) | ||||
| EBITDA | 29.67 M | ||||
| Net Income | 28.43 M | ||||
| Cash And Equivalents | 68.47 M | ||||
| Cash Per Share | 0.75 X | ||||
| Total Debt | 31.86 M | ||||
| Debt To Equity | 0.79 % | ||||
| Current Ratio | 1.82 X | ||||
| Book Value Per Share | 1.09 X | ||||
| Cash Flow From Operations | (33.55 M) | ||||
| Short Ratio | 1.76 X | ||||
| Earnings Per Share | 3.48 X | ||||
| Target Price | 11.5 | ||||
| Number Of Employees | 39 | ||||
| Beta | 1.08 | ||||
| Market Capitalization | 9.1 M | ||||
| Total Asset | 30.66 M | ||||
| Retained Earnings | (254.97 B) | ||||
| Working Capital | (33.28 M) | ||||
| Current Asset | 1.97 M | ||||
| Current Liabilities | 842 K | ||||
| Net Asset | 30.66 M |
About PAVmed Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze PAVmed Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of PAVmed using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of PAVmed Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out PAVmed Piotroski F Score and PAVmed Altman Z Score analysis. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of PAVmed. If investors know PAVmed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about PAVmed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 3.48 | Revenue Per Share | Quarterly Revenue Growth (0.99) | Return On Assets | Return On Equity |
The market value of PAVmed Inc is measured differently than its book value, which is the value of PAVmed that is recorded on the company's balance sheet. Investors also form their own opinion of PAVmed's value that differs from its market value or its book value, called intrinsic value, which is PAVmed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because PAVmed's market value can be influenced by many factors that don't directly affect PAVmed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between PAVmed's value and its price as these two are different measures arrived at by different means. Investors typically determine if PAVmed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PAVmed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.